Vimedimex Medi – Pharma JSC (STC:VMD) Forward Dividend Yield %: 0.00% (As of Jun. 26, 2026)


What is Vimedimex Medi – Pharma JSC Forward Dividend Yield %?

Vimedimex Medi – Pharma JSC STC:VMD Forward Dividend Yield % is 0.00% as of Jun. 26, 2026.

As of today (2026-06-26), the Forward Annual Dividend Yield of Vimedimex Medi – Pharma JSC is 0.00%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Vimedimex Medi – Pharma JSC is 0.00%.

STC:VMD's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.525
* Ranked among companies with meaningful Forward Dividend Yield % only.

Vimedimex Medi – Pharma JSC's Dividends per Share for the three months ended in . 20 was ₫0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Vimedimex Medi – Pharma JSC  (STC:VMD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Vimedimex Medi – Pharma JSC Forward Dividend Yield % Related Terms

STC:VMD vs GOVX, MBVXQ, HSTC: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Vimedimex Medi – Pharma JSC's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimedimex Medi – Pharma JSC Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vimedimex Medi – Pharma JSC's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Vimedimex Medi – Pharma JSC's Forward Dividend Yield % falls into.


Vimedimex Medi – Pharma JSC Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Vimedimex Medi – Pharma JSC (STC:VMD) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Vimedimex Medi – Pharma JSC and its competitors.
Is Vimedimex Medi – Pharma JSC's Forward Dividend Yield % too high?
Vimedimex Medi – Pharma JSC's current Forward Dividend Yield % is 0.00%.
How does Vimedimex Medi – Pharma JSC's Forward Dividend Yield % compare to GOVX and MBVXQ?
Vimedimex Medi – Pharma JSC's Forward Dividend Yield % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Forward Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.53, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Vimedimex Medi – Pharma JSC and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimedimex Medi – Pharma JSC's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimedimex Medi – Pharma JSC stock overvalued right now?
Vimedimex Medi – Pharma JSC (STC:VMD) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Vimedimex Medi – Pharma JSC (STC:VMD), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vimedimex Medi – Pharma JSC Business Description

Address 246 Cong Quynh Street, Pham Ngu Lao Ward, District 1, Ho Chi Minh City, VNM
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.